Thomas L. Haulk

622 total citations
7 papers, 469 citations indexed

About

Thomas L. Haulk is a scholar working on Hepatology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas L. Haulk has authored 7 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 3 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas L. Haulk's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Thomas L. Haulk is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Thomas L. Haulk collaborates with scholars based in United States. Thomas L. Haulk's co-authors include Ross A. Abrams, Robert DeJong, Steven Piantadosi, S. Li, Marti Goemann, Angelo M. De Marzo, Michael A. Carducci, Theodore L. DeWeese, Roger Drew and Nicholas Detorie and has published in prestigious journals such as Radiology, International Journal of Radiation Oncology*Biology*Physics and Gastrointestinal Endoscopy.

In The Last Decade

Thomas L. Haulk

7 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas L. Haulk United States	7	272	248	210	94	75	7	469
Joanne Coleman United States	4	49 0.2×	362 1.5×	107 0.5×	101 1.1×	60 0.8×	6	573
Mary Ann Fritz Germany	6	250 0.9×	304 1.2×	235 1.1×	159 1.7×	180 2.4×	7	622
Santiago Aparo United States	11	80 0.3×	238 1.0×	59 0.3×	65 0.7×	39 0.5×	30	391
Adel Samson United Kingdom	12	164 0.6×	244 1.0×	155 0.7×	15 0.2×	32 0.4×	30	422
Miao-La Ke China	10	48 0.2×	266 1.1×	145 0.7×	44 0.5×	26 0.3×	11	476
Uxua Mancheño Spain	14	164 0.6×	343 1.4×	192 0.9×	15 0.2×	26 0.3×	19	623
Tyler Walther United States	3	124 0.5×	317 1.3×	116 0.6×	26 0.3×	33 0.4×	4	473
Hélène Mouly France	8	43 0.2×	164 0.7×	223 1.1×	64 0.7×	15 0.2×	14	475
Renee N. Georges United States	7	336 1.2×	306 1.2×	352 1.7×	27 0.3×	268 3.6×	9	608
William R. Fair United States	9	69 0.3×	214 0.9×	238 1.1×	331 3.5×	83 1.1×	14	712

Countries citing papers authored by Thomas L. Haulk

Since Specialization

Citations

This map shows the geographic impact of Thomas L. Haulk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas L. Haulk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas L. Haulk more than expected).

Fields of papers citing papers by Thomas L. Haulk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas L. Haulk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas L. Haulk. The network helps show where Thomas L. Haulk may publish in the future.

Co-authorship network of co-authors of Thomas L. Haulk

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas L. Haulk. A scholar is included among the top collaborators of Thomas L. Haulk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas L. Haulk. Thomas L. Haulk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Jones, Richard J., James S. Welsh, Thomas L. Haulk, et al.. (2003). Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin’s or Hodgkin’s lymphoma. International Journal of Radiation Oncology*Biology*Physics. 57(1). 166–171. 6 indexed citations

DeWeese, Theodore L., H. Van der Poel, S. Li, et al.. (2001). A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.. PubMed. 61(20). 7464–72. 299 indexed citations

Epstein, Barry E., et al.. (1999). Metastatic Nonresectable Fibrolamellar Hepatoma. American Journal of Clinical Oncology. 22(1). 22–28. 42 indexed citations

Abrams, Ross A., Louise B. Grochow, Anuradha Chakravarthy, et al.. (1999). Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. International Journal of Radiation Oncology*Biology*Physics. 44(5). 1039–1046. 85 indexed citations

Abrams, Ross A., Ping Liu, Richard F. Ambinder, et al.. (1997). Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation.. Radiology. 203(3). 865–870. 10 indexed citations

Abrams, Ross A., Robert M. Cardinale, Cheryl Enger, et al.. (1997). Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: Experience with cis-platinum-based chemoradiotherapy in 76 patients. International Journal of Radiation Oncology*Biology*Physics. 39(5). 1077–1085. 10 indexed citations

Prindiville, Thomas, et al.. (1990). Bacterial peritonitis following esophageal injection sclerotherapy for variceal hemorrhage. Gastrointestinal Endoscopy. 36(2). 131–133. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact